This paper analyses the promotion of medicines for human use that have already received marketing authorization, when the advertising is made before the resolution on pricing and inclusion in the Spanish National Health Service. This is an issue addressed by […]
Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio […]
Jorge Muñoz, Member of CEFI Board lead the debate on advanced therapies an biological medicinal products. Sol Ruíz, Jefe de División de Productos Biológicos, Terapias Avanzadas y Biotecnología de la Agencia Española de Medicamentos y Productos Sanitarios and Jordi Faus, […]
Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos Innovadores de Farmaindustria and Lluis Alcover, Abogado de Faus y Moliner. Interestingf debate about main […]
On 15 October we had an interesting discussion on Observational Studies on Medications and patient support programmes in the new regulations that aroused a lot of interest. More than 90 people participated in the session with strong participation in questions […]
Superior Court of Justice of the Basque Country, Judicial Review Chamber, Judgment 246/2021 of 30 June resolved positively on a question widely debated in the sector: the possibility of advertising medicinal products that have been approved for sale but have […]
Considerations on the pricing system for medicinal products. Lourdes Fraguas Gadea Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández Public supply of medicines. Doctrine generated by the […]
The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance […]
Available for download. The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook […]
Rosa Romero Sánchez, Presidenta de la Comisión de Sanidad del Congreso de los Diputados and Katia Piñol, Presidenta de CEFI highlight the importance of holding this debate. Pharmaceutical sector and medicinal innovation are constantly searching for health improvement. We need […]
Alberto Dorrego. Abogado socio de Eversheds Sutherland claim for a specific regulación on public procurement for innovative medicines and vaccines. He also highlight the importance of price and hospital offers confidentiality Carme Briera, Cousel de Clifford Chance enter into a […]
Second week of the Pharmaceutical Law Course begin with one of the main issues for innovative medicines. Lead by Javier de Urquía Martí, member of CEFI Board we had as speakers: Jesús García Herrero, Jefe de la intervención de precios […]
12
Page 1 of 2
A foundation for promoting and supporting research and technological development, especially regarding the pharmaceutical industry
Nuestra entidad se encuentra adherida a Confianza Online (Asociación sin ánimo de lucro), inscrita en el Registro Nacional de Asociaciones Grupo 1, Sección 1, número nacional 594400, CIF G85804011, Calle Carrera de San Jerónimo, 18 28014 Madrid (España).. Para más información: (confianzaonline.es).